1656.0000 7.40 (0.45%)
NSE Sep 19, 2025 15:31 PM
Volume: 3.2M
 

1656.00
0.45%
Sharekhan
R&D; spends for the quarter stood at 6% of sales. Management has guided for higher R&D; spends for FY2020 at 7-8% of sales. Major chunk of the spends would be towards the specialty business....
Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
More from Sun Pharmaceutical Industries Ltd.
Recommended